Stepan earnings fall short of estimates on weak surfactants results
21:09 PM | July 24, 2013 | Vincent Valk
Stepan's second-quarter net income rose 6% year-on-year (YOY), to $22.7 million, on net sales up 1%, to $474.4 million. Excluding deferred compensation plan income, however, net income fell 10%, to ...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.